Entera Bio Ltd
ENTX2.060USD
+0.110+5.64%
Horário de mercado （ET）Cotações atrasadas em 15 min
93.57MValor de mercado
PerdaP/L TTM
Mais detalhes de Entera Bio Ltd Empresa
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Informações da empresa
Código da empresaENTX
Nome da EmpresaEntera Bio Ltd
Data de listagemJun 28, 2018
CEOMs. Miranda Jayne Toledano
Número de funcionários18
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 28
EndereçoHadassah / Jerusalem Bio
CidadeJERUSALEM
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal9112002
Telefone97225327151
Sitehttps://enterabio.com/
Código da empresaENTX
Data de listagemJun 28, 2018
CEOMs. Miranda Jayne Toledano
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
324.96K
--
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
291.45K
+163.16%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
134.73K
--
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
64.65K
--
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
47.26K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
46.94K
--
Mr. Ron Abraham Mayron
Mr. Ron Abraham Mayron
Independent Director
Independent Director
--
--
Ms. Dana Yaacov-Garbeli
Ms. Dana Yaacov-Garbeli
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roger J. Garceau, M.D.
Dr. Roger J. Garceau, M.D.
Director
Director
--
--
Dr. Hillel Galitzer
Dr. Hillel Galitzer
Chief Operating Officer
Chief Operating Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
324.96K
--
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
291.45K
+163.16%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
134.73K
--
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
64.65K
--
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
47.26K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
46.94K
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 17 de jul
Atualizado em: qui, 17 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Knoll Capital Management, LLC
12.94%
OPKO Health Inc
8.50%
D.N.A Biomedical Solutions, Ltd.
8.21%
Point72 Asset Management, L.P.
5.93%
Centillion Fund Inc
5.27%
Other
59.14%
Investidores
Investidores
Proporção
Knoll Capital Management, LLC
12.94%
OPKO Health Inc
8.50%
D.N.A Biomedical Solutions, Ltd.
8.21%
Point72 Asset Management, L.P.
5.93%
Centillion Fund Inc
5.27%
Other
59.14%
Tipos de investidores
Investidores
Proporção
Corporation
21.99%
Hedge Fund
21.33%
Individual Investor
2.44%
Investment Advisor
0.70%
Research Firm
0.07%
Investment Advisor/Hedge Fund
0.05%
Venture Capital
0.02%
Other
53.41%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
44
20.97M
46.14%
-173.92K
2025Q1
48
20.87M
47.30%
+2.99M
2024Q4
45
14.59M
39.63%
+276.18K
2024Q3
44
12.66M
34.61%
+129.89K
2024Q2
43
12.40M
34.23%
+1.30M
2024Q1
39
11.33M
31.94%
+147.25K
2023Q4
38
10.84M
34.31%
+2.50M
2023Q3
40
9.31M
32.31%
-70.93K
2023Q2
42
9.22M
32.01%
-186.20K
2023Q1
42
9.45M
32.81%
-129.12K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Knoll Capital Management, LLC
5.88M
12.94%
--
--
Mar 31, 2025
OPKO Health Inc
3.87M
8.5%
+180.00K
+4.88%
May 08, 2025
D.N.A Biomedical Solutions, Ltd.
3.73M
8.21%
--
--
May 08, 2025
Point72 Asset Management, L.P.
2.70M
5.93%
-4.32K
-0.16%
Mar 31, 2025
Centillion Fund Inc
2.40M
5.27%
--
--
May 08, 2025
Schonfeld Strategic Advisors LLC
599.16K
1.32%
-33.16K
-5.24%
Mar 31, 2025
Parkman Healthcare Partners LLC
439.63K
0.97%
+25.90K
+6.26%
Mar 31, 2025
Lieberman (Gerald M)
324.96K
0.71%
--
--
May 08, 2025
Toledano (Miranda Jayne)
110.75K
0.24%
--
--
May 08, 2025
Northern Trust Global Investments Limited
198.83K
0.44%
-13.65K
-6.42%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
